Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03408340 · ClinicalTrials.gov registry record · Phase 4
Paravertebral Nerve Blocks in Neonates
A Phase 4 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT03408340 is a Phase 4 study that was terminated before completion, run by Emory University. The registered enrollment target is 16 participants.
The verdict
NCT03408340, a Phase 4 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study is a prospective, randomized, non-blinded clinical trial examining the use of paravertebral peripheral nerve block in the neonatal and infant populations. The primary aim of this study is to determine the feasibility of studying whether a single-shot paravertebral nerve block is effective in providing intraoperative and postoperative pain control in infants undergoing a thoracotomy for coarctation of the aorta. This will be determined by comparing consumption of narcotics, expressed as morphine equivalents, in the standard of care and intervention groups.
Interventions
- PROCEDURE Paravertebral Nerve Block
- DRUG Standard of Care Anesthesia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2020-07-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03408340
The ClinicalTrials.gov registry entry for NCT03408340 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Paravertebral Nerve Block is the first listed.
NCT03408340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03408340 about?
NCT03408340 is a clinical study titled "Paravertebral Nerve Blocks in Neonates". This study is a prospective, randomized, non-blinded clinical trial examining the use of paravertebral peripheral nerve block in the neonatal and infant populations. The primary aim of this study is to determine the feasibility of studying whether a single-shot paravertebral nerve block is effective...
What is the current status of trial NCT03408340?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2018-07-18. Estimated completion is 2020-07-28.
What interventions are being tested in trial NCT03408340?
The interventions under investigation include: Paravertebral Nerve Block (PROCEDURE), Standard of Care Anesthesia (DRUG).
Who is sponsoring clinical trial NCT03408340?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.